NatureWise Biotech & Medicals Corporation (TPEX:4732)

TPEX:4732 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	127.05	97.68	319.95	112.55	98.97	155.56
Short-Term Investments	282.08	372.71	294.78	362.71	344.41	292.02
Trading Asset Securities	-	-	-	-	50.6	50.29
Cash & Short-Term Investments	409.13	470.39	614.73	475.26	493.98	497.87
Cash Growth	-29.22%	-23.48%	29.35%	-3.79%	-0.78%	5.45%
Accounts Receivable	59.96	60.67	56.73	55.17	64.35	65.48
Other Receivables	2.4	2.42	1.61	1.93	-	-
Receivables	62.36	63.08	58.35	57.1	64.35	65.48
Inventory	70.65	79.46	84.37	82.5	59.56	55.8
Prepaid Expenses	35.12	-	-	-	4.15	-
Other Current Assets	0.17	24.76	13.22	12.15	0.23	4.63
Total Current Assets	577.43	637.69	770.67	627.01	622.26	623.77
Property, Plant & Equipment	9.89	12.48	3.96	8.62	3.63	8.26
Goodwill	-	8.54	8.54	8.54	8.54	8.54
Other Intangible Assets	24.09	17.84	22.85	28.84	33.97	38.93
Long-Term Deferred Tax Assets	13.76	15.17	28.44	20.16	19.14	19.4
Other Long-Term Assets	21.49	21.15	6.13	5.28	5.06	5.66
Total Assets	646.65	712.87	840.59	698.45	692.6	704.57

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	13.45	16.18	12.97	22.98	8.8	22.99
Accrued Expenses	-	29.22	13.54	15.43	22.41	30.53
Current Portion of Leases	4.36	4.78	3.35	4.52	2.7	3.94
Current Income Taxes Payable	1.55	-	8.39	0.1	0.68	1.33
Current Unearned Revenue	6.13	5.15	6.51	5.67	4.34	7.49
Other Current Liabilities	36.36	4.5	5.68	5.59	3.92	2.09
Total Current Liabilities	81.85	59.82	50.44	54.29	42.85	68.37
Long-Term Leases	4.74	6.71	0.06	3.27	-	2.7
Long-Term Deferred Tax Liabilities	1.2	1.56	2.54	3.33	4.24	5.15
Other Long-Term Liabilities	4	4	4	4	4	4
Total Liabilities	91.8	72.1	57.03	64.89	51.09	80.22

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	494.85	493.96	492.9	492.9	492.9	492.9
Additional Paid-In Capital	1.59	194.79	193.65	77.67	70.84	69.13
Retained Earnings	-107.22	-36.96	55.33	64.29	78.81	63.57
Treasury Stock	-26.44	-26.44	-	-	-	-
Comprehensive Income & Other	194.54	-1.01	-0.86	-1.29	-1.04	-1.26
Total Common Equity	557.32	624.35	741.02	633.56	641.51	624.35
Minority Interest	-2.46	16.43	42.54	-	-	-
Shareholders' Equity	554.86	640.78	783.56	633.56	641.51	624.35
Total Liabilities & Equity	646.65	712.87	840.59	698.45	692.6	704.57

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	29.1	11.49	3.4	7.78	2.7	6.64
Net Cash (Debt)	380.03	458.9	611.33	467.48	491.28	491.23
Net Cash Growth	-33.74%	-24.93%	30.77%	-4.84%	0.01%	4.65%
Net Cash Per Share	7.86	9.42	12.27	9.37	9.93	9.96
Filing Date Shares Outstanding	48.13	48.25	49.29	49.2	49.29	49.29
Total Common Shares Outstanding	48.13	48.25	49.29	49.2	49.29	49.29
Working Capital	495.58	577.87	720.23	572.72	579.42	555.41
Book Value Per Share	11.58	12.94	15.03	12.88	13.02	12.67
Tangible Book Value	533.23	597.96	709.62	596.18	599	576.88
Tangible Book Value Per Share	11.08	12.39	14.40	12.12	12.15	11.70
Machinery	-	8.54	7.7	7.58	7.58	7.61
Leasehold Improvements	-	5.19	5.19	5.19	4.88	5.08

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 26, 2026

Data Sources Report a data error